A distinct metabolic signature of human colorectal cancer with prognostic potential

Clinical Cancer Research

Volumn 20, Issue 8, 2014, Pages 2136-2146

  Qiu, Yunping ^a,g   Cai, Guoxiang ^b,c   Zhou, Bingsen ^h   Li, Dan ^f   Zhao, Aihua ^a   Xie, Guoxiang ⁱ   Li, Houkai ^g   Cai, Sanjun ^b,c   Xie, Dong ^d   Huang, Changzhi ^e   Ge, Weiting ^f   Zhou, Zhanxiang ^g   Xu, Lisa X ^a   Jia, Weiping ^a   Zheng, Shu ^f   Yen, Yun ^h   Jia, Wei ^a,i  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c FUDAN UNIVERSITY   (China)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^e CANCER HOSPITAL   (China)

^f ZHEJIANG UNIVERSITY   (China)

^g UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^h CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; MOLECULAR DYNAMICS; ONCOGENE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; TRANSCRIPTOMICS; CLINICAL TRIAL; COLORECTAL NEOPLASMS; ENERGY METABOLISM; FOLLOW UP; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; METABOLOME; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; ENERGY METABOLISM; FEMALE; FOLLOW-UP STUDIES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 84899020281     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1939     Document Type: Article

References (37)

1. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008;7:11-20.
2. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
3. Wellen KE, Thompson CB. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell 2010;40:323-32.
4. Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010;10:267-77.
5. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, et al. Metabolite profiling of human colon carcinoma-deregulation of tca cycle and amino acid turnover. Mol Cancer 2008;7:72.
6. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 2009;69:4918-25.
7. Beyoglu D, Imbeaud S, Maurhofer O, Bioulac-Sage P, Zucman-Rossi J, Dufour JF, et al. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. Hepatology 2013;58:299-38.
8. Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Humpfer E, Spraul M, et al. Metabolic profiling of human lung cancer tissue by 1h high resolution magic angle spinning (hrmas) nmr spectroscopy. J Proteome Res 2010;9:319-32.
9. Jemal A, Bray F, CenterMM,Ferlay J, Ward E, FormanD. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
10. Calvert PM, Frucht H. The genetics of colorectal cancer. Ann Intern Med 2002;137:603-12.
11. Pan L, Qiu Y, Chen T, Lin J,Chi Y, Su M, et al. Anoptimized procedure for metabonomic analysisof rat liver tissueusinggas chromatography/timeof- flight mass spectrometry. J Pharm Biomed Anal 2010;52:589-96.
12. Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, et al. Serum metabolite profiling of human colorectal cancer using gc-tofms and uplc-qtofms. J Proteome Res 2009;8:4844-50.
13. Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, et al. Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res 2012;11:1354-63.
14. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, et al. Metabolomics reveals metabolic biomarkers of crohn's disease. PLoS ONE 2009;4:e6386.
15. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
16. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009;457:910-4.
17. Giskeodegard GF, Grinde MT, Sitter B, Axelson DE, Lundgren S, Fjosne HE, et al. Multivariate modeling and prediction of breast cancer prognostic factors using mr metabolomics. J Proteome Res 2010;9: 972-9.
18. Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (hr-mas nmr) spectroscopy and gas chromatography mass spectrometry (gc/ms). J Proteome Res 2009;8:352-61.
19. Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012;491:364-73.
20. Pieters R, Hunger SP, Boos J, Rizzari C, Silverman L, Baruchel A, et al. L-asparaginase treatment in acute lymphoblastic leukemia: a focus on erwinia asparaginase. Cancer 2011;117:238-49.
21. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-9.
22. Piotto MM, Moussallieh FM, Dillmann B, Imperiale A, Neuville A, Brigand C, et al. Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1h magnetic resonance spectroscopy. Metabolomics 2009;5:292-301.
23. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33.
24. Paton CM, Ntambi JM. Biochemical and physiological function of stearoyl- coa desaturase. Am J Physiol Endocrinol Metab 2009;297:E28-37.
25. Hong BS, Senisterra G, Rabeh WM, Vedadi M, Leonardi R, Zhang YM, et al. Crystal structures of human pantothenate kinases. Insights into allosteric regulation and mutations linked to a neurodegeneration disorder. J Biol Chem 2007;282:27984-93.
26. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005;10:1881-96.
27. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991;51:794-8.
28. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 2006;281:16768-76.
29. Orlowski M, Wilk S. Synthesis of ophthalmic acid in liver and kidney in vivo. Biochem J 1978;170:415-9.
30. Fong MY, McDunn J, Kakar SS. Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS ONE 2011;6:e19963.
31. Oakley AJ, Yamada T, Liu D, Coggan M, Clark AG, Board PG. The identification and structural characterization of c7orf24 as gammaglutamyl cyclotransferase. An essential enzyme in the gamma-glutamyl cycle. J Biol Chem 2008;283:22031-42.
32. Gromov P, Gromova I, Friis E, Timmermans-Wielenga V, Rank F, Simon R, et al. Proteomic profiling of mammary carcinomas identifies c7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker. J Proteome Res 2010;9:3941-53.
33. Wiese AH, Auer J, Lassmann S, Nahrig J, Rosenberg R, Hofler H, et al. Identification of gene signatures for invasive colorectal tumor cells. Cancer Detect Prev 2007;31:282-95.
34. Miyanishi K, Takayama T, Ohi M, Hayashi T, Nobuoka A, Nakajima T, et al. Glutathione s-transferase-pi overexpression is closely associated with k-ras mutation during human colon carcinogenesis. Gastroenterology 2001;121:865-74.
35. Brand A, Leibfritz D, Richter-Landsberg C. Oxidative stress-induced metabolic alterations in rat brain astrocytes studied by multinuclear nmr spectroscopy. J Neurosci Res 1999;58:576-85.
36. Terentis AC, Thomas SR, Takikawa O, Littlejohn TK, Truscott RJ, Armstrong RS, et al. The heme environment of recombinant human indoleamine 2,3-dioxygenase. Structural properties and substrateligand interactions. J Biol Chem 2002;277:15788-94.
37. Zamanakou M, Germenis AE, Karanikas V. Tumor immune escape mediated by indoleamine 2,3-dioxygenase. Immunol Lett 2007;111: 69-75.